BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37675806)

  • 1. Trop-2 Is Highly Expressed in Early Luminal-Like Breast Cancer.
    Coelho RC; Ruppenthal RD; Graudenz MS
    J Histochem Cytochem; 2023 Oct; 71(10):529-535. PubMed ID: 37675806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
    Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
    J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
    Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
    Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.
    Yue Y; Liang J; Wu Y; Tong W; Li D; Cao X; Wang X
    Technol Cancer Res Treat; 2022; 21():15330338221132669. PubMed ID: 36254567
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights from a Long-Term Follow-Up Evaluation of Early Breast Cancer Outcomes by Tumor Subtype.
    Zanardi E; Di Meglio A; Boccardo C; Zinoli L; Salvi S; Rubagotti A
    Oncol Res Treat; 2020; 43(7-8):362-371. PubMed ID: 32512573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
    Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
    Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors on the Positivity for Metastases of the Axillary Lymph Nodes from Primary Breast Cancer.
    Kondov B; Kondov G; Spirovski Z; Milenkovikj Z; Colanceski R; Petrusevska G; Pesevska M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Mar; 38(1):81-90. PubMed ID: 28593885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of Ki67 and clinicopathological features in breast cancer].
    Wang B; Wang X; Wang J; Xuan L; Wang Z; Wang X; Gao J; Zhang H
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):273-5. PubMed ID: 24989913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ERBB gene family in females with breast cancer and its correlation with clinicopathological characteristics of the disease.
    Soosanabadi M; Ghahfarokhi AM; Pourghazi F; Ehtesham N; Mirfakhraie R; Atanesyan L; Keyhani E; Behjati F
    Mol Biol Rep; 2022 Sep; 49(9):8547-8553. PubMed ID: 35763181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial.
    Gluz O; Liedtke C; Huober J; Peyro-Saint-Paul H; Kates RE; Kreipe HH; Hartmann A; Pelz E; Erber R; Mohrmann S; Möbus V; Augustin D; Hoffmann G; Thomssen C; Jänicke F; Kiechle M; Wallwiener D; Kuhn W; Nitz U; Harbeck N
    Ann Oncol; 2016 Jun; 27(6):1035-1040. PubMed ID: 27022068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors.
    Moazzezy N; Ebrahimi F; Sisakht MM; Yahyazadeh H; Bouzari S; Oloomi M
    Asian Pac J Cancer Prev; 2016; 17(1):249-54. PubMed ID: 26838218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of androgen receptor in primary breast carcinoma and its relation with clinicopathologic features, estrogen, progesterone, and her-2 receptor status.
    Vellaisamy G; Tirumalae R; Inchara YK
    J Cancer Res Ther; 2019; 15(5):989-993. PubMed ID: 31603099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between Ki67 and histological grade in breast cancer patients treated with preoperative chemotherapy.
    Petric M; Martinez S; Acevedo F; Oddo D; Artigas R; Camus M; Sanchez C
    Asian Pac J Cancer Prev; 2014; 15(23):10277-80. PubMed ID: 25556461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of lymphangiogenesis and tumor lymphovascular invasion in indonesian breast cancers.
    Widodo I; Ferronika P; Harijadi A; Triningsih FE; Utoro T; Soeripto
    Asian Pac J Cancer Prev; 2013; 14(2):997-1001. PubMed ID: 23621275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study.
    Li FY; Wu SG; Zhou J; Sun JY; Lin Q; Lin HX; Guan XX; He ZY
    PLoS One; 2014; 9(2):e87264. PubMed ID: 24498305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal vs. luminal A breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate markers.
    Ibrahim E; Al-Gahmi AM; Zeenelin AA; Zekri JM; Elkhodary TR; Gaballa HE; Fawzy EE; El sayed ME; Alzahrani MS
    Med Oncol; 2009; 26(3):372-8. PubMed ID: 19034706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathobiology of HER 2 positive small invasive (T1a,b) breast cancer: "A wolf in sheep's clothing".
    Bezić J; Šamija Projić I; Projić P; Meljanac Salopek K; Živković PM; Božić J; Tomić S
    Pathol Res Pract; 2017 Dec; 213(12):1510-1514. PubMed ID: 29033181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
    Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
    Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer molecular subtypes and associations with clinicopathological characteristics in Iranian women, 2002- 2011.
    Kadivar M; Mafi N; Joulaee A; Shamshiri A; Hosseini N
    Asian Pac J Cancer Prev; 2012; 13(5):1881-6. PubMed ID: 22901141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.